FDA Inspection 1314652 — Robinson Pharma, Inc.

Robinson Pharma, Inc. — FEI 3023449887

The FDA completed an inspection of Robinson Pharma, Inc. on April 29, 2026 in Santa Ana, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 29, 2026
Fiscal Year
2026
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Santa Ana, CA (United States)

Citations

IDCFRDescription
1595321 CFR 111.113(a)(1)Quality control production, process control; material review, disposition
2284721 CFR 111.70(e)Specifications - finished dietary supplement